Abbott Diabetes Monitor Patent Revived By Fed. Circ.
Ruling that the U.S. Patent and Trademark Office had misconstrued two Abbott Diabetes Care Inc. glucose monitoring patents to include features the patents were actually disparaging in prior art, the Federal...To view the full article, register now.
Already a subscriber? Click here to view full article